Population aging leads to the emergence of pathologies that can sometimes be mistaken for irreversible degenerative processes. One of the most relevant conditions in this context is Normal Pressure Hydrocephalus (NPH), also known as Hakim-Adams syndrome. At the Arr\u00e1ez Institute, we consider the correct identification of this pathology to be fundamental, as, unlike other forms of dementia, NPH is potentially reversible through precise neurosurgical intervention.<\/p>\n\n\n\n
Normal Pressure Hydrocephalus (NPH) is characterized by an abnormal accumulation of cerebrospinal fluid (CSF) in the brain's ventricles. What distinguishes this condition is that, despite the increased fluid volume, intracranial pressure remains within normal or only slightly elevated ranges intermittently. This ventricular dilation exerts mechanical pressure on adjacent brain structures, altering their function and leading to very specific symptoms.<\/p>\n\n\n\n
The clinical suspicion of Normal Pressure Hydrocephalus (NPH) is traditionally based on the presence of the so-called \u00abHakim's triad,\u00bb a set of three cardinal symptoms that usually appear progressively. Identifying these signs in a timely manner is crucial to prevent permanent neurological damage.<\/p>\n\n\n\n
The first symptom to appear is usually an alteration in gait. Patients present a characteristic way of walking: short steps, a wide base of support, and a feeling that their feet are \u00abstuck to the floor\u00bb (magnetic gait). This symptom is often mistaken for joint problems or Parkinson's disease.<\/p>\n\n\n\n
Secondly, urinary incontinence develops. Initially, the patient experiences frequent urinary urgency, which can progress to total loss of sphincter control. The presence of these three elements in an elderly patient should always prompt a specialized consultation with neurosurgery.<\/p>\n\n\n\n
Cognitive decline finally appears. This manifests as slowness in information processing, lack of attention, apathy, and short-term memory failures. It is common for families to attribute these changes to \u00abnormal aging\u00bb or Alzheimer's disease, which delays the correct diagnosis.<\/p>\n\n\n\n
At Arr\u00e1ez Institute, we employ advanced diagnostic protocols to confirm HCA. In addition to magnetic resonance imaging (MRI) to observe ventricular dilation, we perform dynamic tests such as the infusion test or the high-volume spinal fluid removal test (Tap Test). If the patient experiences a temporary improvement in their gait after CSF removal, the chances of success with surgery are very high.<\/p>\n\n\n\n
Once the diagnosis is confirmed, the treatment of choice is the implantation of a cerebrospinal fluid (CSF) shunt system. This intervention aims to drain excess fluid from the brain's ventricles into another body cavity where it can be reabsorbed, usually the peritoneum (ventriculoperitoneal shunt).<\/p>\n\n\n\n
Modern neurosurgery has advanced significantly in the design of these devices. Currently, we use programmable valves that allow the drainage pressure to be adjusted externally using a magnetic device, without the need for further interventions. This is fundamental for personalizing treatment according to the changing needs of each patient and avoiding complications such as overdrainage or underdrainage.<\/p>\n\n\n\n
The response to treatment is typically very satisfactory, especially concerning gait and sphincter control. Many patients regain the ability to walk independently and experience a notable improvement in their cognitive functions and sphincter control. The key to success lies in early intervention; the sooner pressure is relieved from the brain tissue, the better the long-term functional prognosis will be.<\/p>\n\n\n\n